Cuba produces nano-pharmaceutical products

Cuba has just announced the first pharmaceutical product manufactured by nanotechnology - a drug that helps the immune system fight graft rejection in tissue transplant surgery.

The Communist Party of Cuba's Grama newspaper, on September 23, quoted lead researcher Dario Lopez, who said the main advantages of the new drug product could be as effective as the drugs produced by public Traditional technology, although the dose is three times lower, simultaneously reduces the side effects of drugs.

According to Lopez, the drug is designed to be water-soluble, in which the immunosuppressant melts into the shape of nanoparticles in microcapsules.

In addition to preventing graft rejection, this product is also used in the treatment of arthritis.

Nanotechnology is an area of ​​applied science that studies microscopic materials with a size of only one to 100 nanometers.

This technology has also been applied to industrial production, health care and many other purposes.

Cuba is a country with a microbiological research industry focusing primarily on the production of vaccines.

It is estimated that this industry annually brings about 400 million USD to the Caribbean island nation.